Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Extreme equity market concentration and rising Treasury yields have created a pronounced valuation disparity between momentum-driven technology giants and fundamentally sound, cash-generative value franchises.
Full Quick Take
Extreme equity market concentration and rising Treasury yields have created a pronounced valuation disparity between momentum-driven technology giants and fundamentally sound, cash-generative value franchises.
Elevated Treasury yields and energy volatility have compressed mid-cap multiples, creating selective opportunities in structural AI infrastructure and market-share gainers that can outgrow end markets while cyclical exposure is prudently trimmed.
Full Quick Take
Elevated Treasury yields and energy volatility have compressed mid-cap multiples, creating selective opportunities in structural AI infrastructure and market-share gainers that can outgrow end markets while cyclical exposure is prudently trimmed.
Disciplined capital pool allocation across secular compounders, real asset inflation hedges, and reversionary turnarounds positions the portfolio to harvest idiosyncratic cash flow inflection while sidestepping excessive leverage.
Full Quick Take
Disciplined capital pool allocation across secular compounders, real asset inflation hedges, and reversionary turnarounds positions the portfolio to harvest idiosyncratic cash flow inflection while sidestepping excessive leverage.
Constructive on US small-cap growth compounders driven by enterprise AI adoption and IT capital investment, initiating new positions in $SMTC, $MANH, and $THG while divesting supply-constrained holdings.
Full Quick Take
Constructive on US small-cap growth compounders driven by enterprise AI adoption and IT capital investment, initiating new positions in $SMTC, $MANH, and $THG while divesting supply-constrained holdings.
Capitalizing on small-cap market volatility by expanding exposure to economically sensitive cyclicals at historic valuation discounts to large caps, funding new longs in Permian Resources and Konecranes while redeploying capital from M&A exits.
Full Quick Take
Capitalizing on small-cap market volatility by expanding exposure to economically sensitive cyclicals at historic valuation discounts to large caps, funding new longs in Permian Resources and Konecranes while redeploying capital from M&A exits.
Constructive on Asian equities, exploiting retail margin unwinds to accumulate dominant semiconductor leaders like SK hynix while initiating positions in non-AI structural compounders across Indian healthcare and Korean chip equipment.
Full Quick Take
Constructive on Asian equities, exploiting retail margin unwinds to accumulate dominant semiconductor leaders like SK hynix while initiating positions in non-AI structural compounders across Indian healthcare and Korean chip equipment.
Capitalizing on small-cap market volatility and rate pressures to initiate new positions in asset-backed industrial and financial compounders, while harvesting gains from takeover targets.
Full Quick Take
Capitalizing on small-cap market volatility and rate pressures to initiate new positions in asset-backed industrial and financial compounders, while harvesting gains from takeover targets.
Cautious on elevated broad-market valuations and rising rate pressures, leaning into high-quality healthcare and industrials while initiating longs in $GNRC, $RIG, and $ESAB.
Full Quick Take
Cautious on elevated broad-market valuations and rising rate pressures, leaning into high-quality healthcare and industrials while initiating longs in $GNRC, $RIG, and $ESAB.
Constructive on resilient SMID-cap compounders while maintaining strict valuation discipline amid rate hikes and energy inflation, selectively initiating longs in $GWRE, $TYL, and $BF-B while exiting thesis-impaired holdings like $BOOT and $WAY.
Full Quick Take
Constructive on resilient SMID-cap compounders while maintaining strict valuation discipline amid rate hikes and energy inflation, selectively initiating longs in $GWRE, $TYL, and $BF-B while exiting thesis-impaired holdings like $BOOT and $WAY.
Constructive on secular small-cap compounders, rotating capital from Phase I AI infrastructure into Phase II software applications and from life sciences into medical devices while maintaining cash buffers.
Full Quick Take
Constructive on secular small-cap compounders, rotating capital from Phase I AI infrastructure into Phase II software applications and from life sciences into medical devices while maintaining cash buffers.
Constructive on cash-generative microcap compounders with self-funding growth models, reducing discretionary consumer exposure while consolidating trade education into $UTI and holding high-conviction infrastructure and identity software leaders.
Full Quick Take
Constructive on cash-generative microcap compounders with self-funding growth models, reducing discretionary consumer exposure while consolidating trade education into $UTI and holding high-conviction infrastructure and identity software leaders.
Constructive on structural innovation themes, using cyclical pullbacks to add high-conviction positions in $MTZ, $BDC, and $CINT across infrastructure, physical AI, and IT modernization while navigating mega-cap tech concentration risks.
Full Quick Take
Constructive on structural innovation themes, using cyclical pullbacks to add high-conviction positions in $MTZ, $BDC, and $CINT across infrastructure, physical AI, and IT modernization while navigating mega-cap tech concentration risks.
Constructive on durable international growth leaders across AI infrastructure, digital platforms, and specialist healthcare, maintaining high active share while exercising patience through cyclical transport and semiconductor volatility.
Full Quick Take
Constructive on durable international growth leaders across AI infrastructure, digital platforms, and specialist healthcare, maintaining high active share while exercising patience through cyclical transport and semiconductor volatility.
Exploiting rate-driven multiple compression and summer dispersion, the fund redeployed capital by establishing a new position in Align Technology and exiting Novo Nordisk and Xylem while selectively topping up beaten-down growth compounders.
Full Quick Take
Exploiting rate-driven multiple compression and summer dispersion, the fund redeployed capital by establishing a new position in Align Technology and exiting Novo Nordisk and Xylem while selectively topping up beaten-down growth compounders.
Constructive on small-cap growth amid attractive historical valuations and resilient earnings, reallocating capital from AI hardware and cyclicals into select software and healthcare compounders.
Full Quick Take
Constructive on small-cap growth amid attractive historical valuations and resilient earnings, reallocating capital from AI hardware and cyclicals into select software and healthcare compounders.
Constructive on municipal fixed income amid decade-high yields, maintaining a duration-neutral barbell posture focused on 5%-plus coupons, new-issue concessions, and high-grade essential service revenue bonds while avoiding vulnerable hospital issuers.
Full Quick Take
Constructive on municipal fixed income amid decade-high yields, maintaining a duration-neutral barbell posture focused on 5%-plus coupons, new-issue concessions, and high-grade essential service revenue bonds while avoiding vulnerable hospital issuers.
Positioned defensively in high-quality small caps, expanding overweights in cash-generative industrials and disciplined energy operators while initiating longs in Morningstar and avoiding speculative momentum in utilities.
Full Quick Take
Positioned defensively in high-quality small caps, expanding overweights in cash-generative industrials and disciplined energy operators while initiating longs in Morningstar and avoiding speculative momentum in utilities.
Positioned defensively in high-quality consumer staples, healthcare, and insurance while underweighting high-multiple technology and discretionary retail, initiating new longs in Honeywell Aerospace and Equifax while divesting Target amid macro headwinds.
Full Quick Take
Positioned defensively in high-quality consumer staples, healthcare, and insurance while underweighting high-multiple technology and discretionary retail, initiating new longs in Honeywell Aerospace and Equifax while divesting Target amid macro headwinds.
Outperforming the Russell Midcap Growth Index's 5.84% decline through resilient selection in healthcare and communication services, while actively deploying into enterprise software on pullbacks.
Full Quick Take
Outperforming the Russell Midcap Growth Index's 5.84% decline through resilient selection in healthcare and communication services, while actively deploying into enterprise software on pullbacks.
Outperforming the benchmark by 7.4 percentage points driven by an underweight in Information Technology and stock selection in Health Care, while holding zero portfolio turnover.
Full Quick Take
Outperforming the benchmark by 7.4 percentage points driven by an underweight in Information Technology and stock selection in Health Care, while holding zero portfolio turnover.
Broyhill underperformed broad benchmarks in the first half of 2026 due to an April surge in momentum technology and semiconductors, but captured solid gains from idiosyncratic earnings strength in core holdings.
Full Quick Take
Broyhill underperformed broad benchmarks in the first half of 2026 due to an April surge in momentum technology and semiconductors, but captured solid gains from idiosyncratic earnings strength in core holdings.
Rivemont is positioned for a major sector rotation away from technology toward healthcare and Canadian financials. The fund has aggressively overweighted healthcare real estate, pharmaceuticals, and biotechnology for resilience and lower volatility.
Full Quick Take
Rivemont is positioned for a major sector rotation away from technology toward healthcare and Canadian financials. The fund has aggressively overweighted healthcare real estate, pharmaceuticals, and biotechnology for resilience and lower volatility.
Auxier positions in AI infrastructure providers earning strong profits supplying vital hardware and connectivity rather than hyperscalers chasing uncertain AI model profitability.
Full Quick Take
Auxier positions in AI infrastructure providers earning strong profits supplying vital hardware and connectivity rather than hyperscalers chasing uncertain AI model profitability.
Bilbel Capital runs concentrated deep value portfolio of five positions bought under 3.5x earnings with strong balance sheets. Lead position Water Oasis trades at fraction of cash holdings while dominating Hong Kong beauty services with consolidation runway.
Full Quick Take
Bilbel Capital runs concentrated deep value portfolio of five positions bought under 3.5x earnings with strong balance sheets. Lead position Water Oasis trades at fraction of cash holdings while dominating Hong Kong beauty services with consolidation runway.
SpaceX IPO'd at $1.77 trillion after deploying the world's largest AI compute cluster. Hyperscalers are spending $700 billion on AI infrastructure with $1.4 trillion in backlogs, while agentic workloads drive token demand up 300x.
Full Quick Take
SpaceX IPO'd at $1.77 trillion after deploying the world's largest AI compute cluster. Hyperscalers are spending $700 billion on AI infrastructure with $1.4 trillion in backlogs, while agentic workloads drive token demand up 300x.
Diamond Hill's Small Cap Strategy outperformed the Russell 2000 by 255 basis points in Q2 2026, driven by stock selection in health care and industrials.
Full Quick Take
Diamond Hill's Small Cap Strategy outperformed the Russell 2000 by 255 basis points in Q2 2026, driven by stock selection in health care and industrials.
The fund initiated Copart after a 50% decline and added to healthcare and cable broadband positions trading below valuations. Strong performance from Alphabet, Robert Half, and H&R Block was offset by cable devastation despite 20%+ earnings yields.
Full Quick Take
The fund initiated Copart after a 50% decline and added to healthcare and cable broadband positions trading below valuations. Strong performance from Alphabet, Robert Half, and H&R Block was offset by cable devastation despite 20%+ earnings yields.
Outperforming its benchmark by capitalizing on attractive tax-equivalent yields in high yield munis. Healthcare bonds drove consistent returns on improving fundamentals while infrastructure bonds rebounded on financing progress.
Full Quick Take
Outperforming its benchmark by capitalizing on attractive tax-equivalent yields in high yield munis. Healthcare bonds drove consistent returns on improving fundamentals while infrastructure bonds rebounded on financing progress.
Hotchkis & Wiley underperformed in Q2 2026 by avoiding the AI-driven semiconductor rally they view as a speculative bubble with unsustainable valuations.
Full Quick Take
Hotchkis & Wiley underperformed in Q2 2026 by avoiding the AI-driven semiconductor rally they view as a speculative bubble with unsustainable valuations.
The Touchstone Core Municipal Bond Fund slightly underperformed its benchmark in Q2 2026. The Fund's barbell yield curve positioning contributed positively amid significant curve flattening.
Full Quick Take
The Touchstone Core Municipal Bond Fund slightly underperformed its benchmark in Q2 2026. The Fund's barbell yield curve positioning contributed positively amid significant curve flattening.
Wasatch Small Cap Growth trailed the benchmark in Q2 2026 as speculative AI stocks reached dot-com-era valuations, but the managers maintain conviction in their quality-focused approach. Portfolio fundamentals remain strong with 20%+ earnings growth across many holdings.
Full Quick Take
Wasatch Small Cap Growth trailed the benchmark in Q2 2026 as speculative AI stocks reached dot-com-era valuations, but the managers maintain conviction in their quality-focused approach. Portfolio fundamentals remain strong with 20%+ earnings growth across many holdings.
Vulcan owns exceptional businesses at 50 cents on the dollar with values compounding steadily despite near-term underperformance. Healthcare insurers UnitedHealth and Elevance are recovering from post-Covid pressure.
Full Quick Take
Vulcan owns exceptional businesses at 50 cents on the dollar with values compounding steadily despite near-term underperformance. Healthcare insurers UnitedHealth and Elevance are recovering from post-Covid pressure.
VELA International underperformed by 700 basis points in Q2 2026 as AI mania drove semiconductors higher while the fund's value-oriented technology holdings suffered.
Full Quick Take
VELA International underperformed by 700 basis points in Q2 2026 as AI mania drove semiconductors higher while the fund's value-oriented technology holdings suffered.
The manager executed high portfolio turnover, adding eighteen new positions across data center hardware, software, and consumer services while maintaining discipline around price targets.
Full Quick Take
The manager executed high portfolio turnover, adding eighteen new positions across data center hardware, software, and consumer services while maintaining discipline around price targets.
Riverwater's microcap strategy lagged the Russell Microcap Index in Q2 2026 as speculation dominated, with pre-revenue biotech, crypto, and unproven AI narratives leading. Quality discipline kept the portfolio behind despite solid absolute returns.
Full Quick Take
Riverwater's microcap strategy lagged the Russell Microcap Index in Q2 2026 as speculation dominated, with pre-revenue biotech, crypto, and unproven AI narratives leading. Quality discipline kept the portfolio behind despite solid absolute returns.
T. The Fund is shifting AI exposure toward technology beneficiaries while emphasizing themes with proven cash flows in healthcare, insurance, and commodities.
Full Quick Take
T. The Fund is shifting AI exposure toward technology beneficiaries while emphasizing themes with proven cash flows in healthcare, insurance, and commodities.
Driven by strong performance from Knowles, Generac, and Madison Square Garden Entertainment. The fund added five new positions including Haemonetics, Houlihan Lokey, Masco, Progressive, and Royal Caribbean, while exiting three names to redeploy capital.
Full Quick Take
Driven by strong performance from Knowles, Generac, and Madison Square Garden Entertainment. The fund added five new positions including Haemonetics, Houlihan Lokey, Masco, Progressive, and Royal Caribbean, while exiting three names to redeploy capital.
Small-cap growth navigated Q1 volatility with data center infrastructure holdings driving outperformance as hyperscalers committed nearly $800 billion in AI capex. Energy spiked on Iran strikes but appears temporary.
Full Quick Take
Small-cap growth navigated Q1 volatility with data center infrastructure holdings driving outperformance as hyperscalers committed nearly $800 billion in AI capex. Energy spiked on Iran strikes but appears temporary.
RS Large Cap Value underperformed in Q2 2026.87% for the Russell 1000 Value Index. Market leadership shifted from hyperscalers to AI infrastructure providers.
Full Quick Take
RS Large Cap Value underperformed in Q2 2026.87% for the Russell 1000 Value Index. Market leadership shifted from hyperscalers to AI infrastructure providers.
The manager re-entered NVIDIA at attractive valuations while trimming momentum winners back to optionality. Healthcare presents compelling opportunities with improving fundamentals and multiple compression creating entry points.
Full Quick Take
The manager re-entered NVIDIA at attractive valuations while trimming momentum winners back to optionality. Healthcare presents compelling opportunities with improving fundamentals and multiple compression creating entry points.
Frank Value Fund pursues catalyst-unlocking value in mid-caps trading at 10x earnings, deliberately avoiding the AI Big 10 concentration that mirrors 2000 bubble dynamics.
Full Quick Take
Frank Value Fund pursues catalyst-unlocking value in mid-caps trading at 10x earnings, deliberately avoiding the AI Big 10 concentration that mirrors 2000 bubble dynamics.
Right Tail Capital established a position in HCA Healthcare, the largest US for-profit hospital operator with dominant market positions in high-growth Sunbelt markets.
Full Quick Take
Right Tail Capital established a position in HCA Healthcare, the largest US for-profit hospital operator with dominant market positions in high-growth Sunbelt markets.